diaziquone has been researched along with Bone Marrow Diseases in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (83.33) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bedikian, AY; Benjamin, RS; Burgess, MA; Feun, LG; Fields, WS; Leavens, ME; Obbens, EA; Savaraj, N; Stewart, DJ; Yung, WK | 1 |
| Bruntsch, U; Cavalli, F; Høst, H; Joss, R; Pinedo, H; Renard, G; Rozencweig, M; van Glabbeke, M | 1 |
| Ettinger, LJ; Hammond, GD; Krailo, MD; Krivit, WA; Ru, N; Ruccione, KS | 1 |
| Dicke, KA; Spitzer, G | 1 |
| Ettinger, LJ; Hammond, GD; Krailo, M; Krivit, W; Ruccione, KS | 1 |
| Bukowski, R; Crawford, ED; Kirby, R; O'Bryan, RM; Rivkin, SE; Stephens, RL | 1 |
1 review(s) available for diaziquone and Bone Marrow Diseases
| Article | Year |
|---|---|
Evaluation of the use of high-dose cytoreduction with autologous marrow rescue in various malignancies.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Aziridines; Benzoquinones; Bone Marrow Diseases; Bone Marrow Transplantation; Breast Neoplasms; Carcinoma, Small Cell; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Evaluation; Hodgkin Disease; Humans; Leukemia; Lung Neoplasms; Lymphoma; Neoplasm Metastasis; Neoplasms; Neuroblastoma; Transplantation, Autologous | 1986 |
1 trial(s) available for diaziquone and Bone Marrow Diseases
| Article | Year |
|---|---|
A phase II study of diaziquone in children with recurrent or progressive solid tumors. Report from the Childrens Cancer Study Group.
Topics: Adolescent; Adult; Antineoplastic Agents; Aziridines; Benzoquinones; Bone Marrow Diseases; Child; Child, Preschool; Drug Evaluation; Humans; Infant; Lymphoma; Neoplasm Recurrence, Local; Neoplasms | 1990 |
4 other study(ies) available for diaziquone and Bone Marrow Diseases
| Article | Year |
|---|---|
A phase II trial of 2,5,-diaziridinyl 3,6-bis (carboethoxy amino) 1,4-benzoquinone (AZQ, NSC 182986) in recurrent primary brain tumors.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Astrocytoma; Aziridines; Azirines; Benzoquinones; Bone Marrow Diseases; Brain Neoplasms; Drug Evaluation; Glioblastoma; Glioma; Humans; Middle Aged; Neoplasm Recurrence, Local | 1984 |
Phase II trial of diaziquone (AZQ) in advanced malignant melanoma.
Topics: Adult; Aged; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Blood Cell Count; Bone Marrow Diseases; Drug Administration Schedule; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Melanoma; Middle Aged; Soft Tissue Neoplasms | 1983 |
A phase II study of diaziquone in childhood leukemia: a report from the Children's Cancer Study Group.
Topics: Adolescent; Adult; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Bone Marrow Diseases; Brain Neoplasms; Child; Child, Preschool; Drug Evaluation; Female; Humans; Infant; Leukemia; Male | 1988 |
High dose AZQ in renal cancer. A Southwest Oncology Group phase II study.
Topics: Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Bone Marrow Diseases; Carcinoma, Renal Cell; Drug Evaluation; Humans; Kidney Neoplasms; Leukocyte Count; Platelet Count | 1986 |